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BACKGROUND: From all of human papillomaviruses (HPV) genotypes capable of causing cervical cancer, it is estimated that 70 
percent are HPV-16 and HPV-18. HPV-16 can infect the 
tissues in single infection or together with other high-risk 
types of HPV, and the most common is with HPV-18. The 
origin of HPV can be identified by its phylogenetic tree. The 
aim of this study was to determine the phylogeny of HPV-16 
and HPV-18 multiple infection in cervical cancer, whether 
both HPVs were from the same origin.
METHODS: Cervical tissue biopsies (n=33) were obtained 
from Hasan Sadikin Hospital in the period of September 
to November 2016. HPV genotyping test was performed 
to confirm the HPV-16 and HPV-18 multiple infection. 
L1 gene of both HPV-16 and HPV-18 were sequenced for 
phylogenetic analysis. 
RESULTS: Phylogenetic analysis of L1 HPV-16 and HPV-
18 showed the closest relationship with sequence from 
China and Thailand, respectively.
CONCLUSION: HPV-16 and HPV-18 multiple infection 
of a cervical cancer patient from Dr. Hasan Sadikin General 
Hospital Bandung showed a very close L1 phylogeny 
relationship with isolate from Asian region. 
KEywORDS:  HPV-16, HPV-18, multiple infection, 
cervical cancer, Bandung  
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Introduction
Cervical cancer is the fourth most common cancer in women 
worldwide, after breast cancer, colorectal cancer and lung 
cancer.(1) In Indonesia, cervical cancer is the second 
prevalent female cancer after breast cancer, affecting almost 
a hundred thousand women in 2013.(1) According to the 
Ministry of Health Republic of Indonesia in its Basic Health 
Research data (Riset Kesehatan Dasar/RISKESDAS), it is 
estimated that East Java, West Java and Central Java have 
the highest number of cervical cancer cases in Indonesia.(1)
Human papillomaviruses (HPV) are the causative agents of 
cervical cancer, with HPV-16 and HPV-18 are infecting for 
70% of cervical cancer cases.(2) Chronic infection of high 
risk HPV can lead to cervical cancer. HPV-16 can infect the 
tissues along with other high-risk HPV types. Study in Dr. 
Hasan Sadikin general Hospital has shown that almost 90% 
of the cervical cancer patients were multiply infected by 
HPV-16 in combination with HPV-18, HPV-45, or HPV-52, 
as the most prevalent types being infected in combination 
with HPV-18.(3)
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 HPVs are small nonenveloped DNA viruses. HPV 
genomes comprise double-stranded circular DNA, 
approximately 8000 bp in size, which contain early region, 
late region and long control region (LCR).(4) The HPV 
DNA encodes eight early genes (E1 to E8), and two late 
or structural genes (L1 and L2). E protein plays role in 
pathogenesis of HPV, meanwhile L proteins are structural 
protein. L1 proteins are encoded by L1 gene located in late 
region of HPV genome approximately 1500 bp in size.
(5) L1 is the major capsid protein that also plays a role 
in attachment to the host cell and can initiate replication 
by binding to integrins on the surface of host cells.(5,6) 
L1 protein is also used as a template for cervical cancer 
preventive vaccine making. There are three kinds of 
preventive cervical cancer vaccine, which are bivalent 
vaccine (cervarix®) to protect against HPV-16 and HPV-
18, tetravalent vaccine (Gardasil®) to protect against HPV-
16, 18, -6, -11 and nonavalent vaccine (Gardasil®) which 
protects against infection with HPV type 6, 11, 16, 18, 31, 
33, 45, 52 and 58. These three vaccines contain synthetic L1 
protein which is identical with the original L1 HPV protein, 
this vaccine is called virus-like particle (VLP).(7,8) 
 Genotyping is an analysis to determine various type of 
HPVs, it is important because each HPV type has different 
oncogenic potential. Distinct HPV type is established when 
HPV has more than 10% difference in nucleotide sequence 
of the L1 open reading frame (ORF) from HPV genome. 
HPV intratypic variants are defined as having more than 
98% sequence similarity compared to the prototype 
strain, whereas HPV subtypes have 2-10% difference in 
nucleotide sequence.(9) Variant intratype of HPV L1 gene 
is distributed geographically, this genetic variant influences 
the  pathogenesis of the virus and the difference of epitope 
that can change antibody structure of immune response.(10) 
Our previous study showed that many variants of HPV-16 
genotypes in single infection were from different origins 
(Sahiratmadja, unpublished data). Separated analysis in 
single infection and multiple infection is needed because 
each HPV type has different oncogenic potential and genetic 
variant. Genetic variant influences the pathogenesis of the 
virus and the difference of epitope that can change antibody 
structure of immune response. If two or more different type 
of HPV (HPV-16 and HPV-18 in this study) infect together 
in the cervical cancer tissue have origin differences, then it 
is possible that different type of vaccines are needed so the 
prevention will be more effective. 
 Therefore, the aim of this study was to determine 
the variants in multiple infection of HPV-16 and HPV-18 
Methods
Study Design
This study was part of the ‘Cervical Cancer and HPV Study’ 
by the Center for Oncology, Dr. Hasan Sadikin General 
Hospital/Faculty of Medicine Universitas Padjadjaran. 
Ethical  clearance  was  granted  from  the  Faculty  of 
Medicine Universitas Padjadjaran No. 874/UN6.C1.3.2/
KEPK/PN/2016. 
 The study design was descriptive, using cervical 
biopsies isolates taken from the period of September to 
November 2016. Inclusion criteria were biopsies infected 
with both HPV-16 and HPV-18
DNA Isolation and HPV L1 Sequence Analysis
DNA was isolated from cervical cancer biopsied tissue 
using QIAamp DNA Mini Kit provided protocol (Qiagen, 
Hilden, Germany) and subjected to HPV genotyping test 
from KALGEN laboratory. Only samples infected with 
multiple HPV-16 and HPV-18 were further sequenced for 
L1 gene, using primers as followed: for HPV-16 L1 gene 
forward primer and reverse primer sequences were 5′-AC
GGTACCCAGGTGACTTTTATTTACATCC-3′ and  5′-TA
AGTCGACCAGCTTACGTTTTTTGC-3′, respectively, as 
designed previously (11). For HPV-18 L1 forward primer 
and reverse primer were 5′-CCCGAATTCATGTGCCTG
TATACACGGGTC-3′ and 5′-CCCCTCGAGTTACTTC
CTGGCACGTACACG-3′, respectively. (Genebank data 
available from www.ncbi.nlm.nih.gov with Accession 
number EU834744.1) PCR condition used in this study 
was initial denaturation at  95°C for 3 minutes, followed 
by 35 cycles of denaturation phase at  95°C for 30 seconds; 
annealing phase for 30 seconds at  48.8°C or at 53°C for 
HPV-16 or for HPV-18, respectively; and elongation phase 
at 72°C for 1.5 minutes. Final extension was performed at 
72°C for 5 minutes. Imaging of PCR result was depicted 
by using electrophoresis on 1% agarose gel at 100 volt, for 
30 minutes. L1 gene of HPV-16 and HPV-18 were further 
sequenced at sequencing service company (First Base, 
Selangor, Malaysia). Material transfer was agreed according 
to company’s regulation.
that infect together in the cervical cancer tissue, based on 
phylogenetic analysis. The result of this study is expected 
to be used as a reference for further research in mapping 
of HPV variants for cervical cancer preventive vaccine 
development in Indonesia.
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Results
During April and November 2016, there were 66 women 
recently diagnosed with cervical cancer and agreed to 
participate in this study. The DNA of 30 biopsy samples were 
degraded due to formalin addition during biopsy collection, 
and thus only 36 DNA were further HPV genotyped. The 
Data Analysis and Phylogenetic Tree Construction
Sequence data analysis was performed (Bioedit software 
7.2.5 version) and compared to the nucleotides obtained from 
the study with available data from GeneBank. Alignment 
of the nucleotides was conducted using nucleotide BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). To construct 
phylogenetic tree, additional HPV-16 and -18 L1 sequences 
were downloaded from GeneBank (https://www.ncbi.nlm.
nih.gov/genbank). The reference number of sequences 
downloaded were depicted in Table 1. A neighbor joining 
phylogenetic tree was constructed with MEGA6 software 
and the tree topologies were evaluated using bootstrap 
replicate 1,000 times. 
L1 HPV-16 L1 HPV-18
KU951191.1 (China 1) KU707792.1 (Netherland 1)
KU707590.1 (Netherland 1) KU721791.1 (China 1)
AB889494.1 (Japan 1) KC470209.1 (America 1)
HQ644236.1 (America 1) GQ180792.1 (Thailand 1)
KU951194.1 (China 2) EF202145.1 (America 2)
KU951177.1 (China 3) KU707747.1 (Netherland 2)
KU707672.1 (Netherland 2) KU721790.1 (China 2)
JQ004099.1 (Thailand) GQ180791.1 (Thailand 2)
HQ644248.1 (America 2) AY262282.1 (America 3)
EU430680.1 (China 4) KU707812.1 (Netherland 3)
LC193821.1 (Japan) KC470211.1 (America 4)
KU951195.1 (China 5) EU834744.1 (Korea)








Table 1. The reference number list of sequences.
















Table 2. The percentage of HPV genotypes in 33 patients with 
cervical cancer.
genotype data revealed that HPV-16 and HPV-18 were the 
most dominant HPV that infect the cervical tissue in single 
infection (Table 2). 
 In this study only one multiple infection of cervical 
cancer by HPV-16 and HPV-18 was present, therefore, 
only one sample was further analyzed for its phylogeny. 
This biopsy was obtained from a newly diagnosed cervical 
cancer woman aged 28 years old, P1A0, with chief 
complain of vaginal bleeding and foul-itchy discharge. 
Histopathological examination showed a follicular 
cervicitis. After consent, DNA from biopsy was isolated and 
L1 gene were successfully amplified with size of ~1500 bp 
as shown in Figure 1. 
 Phylogenetic analysis of L1 HPV-16 showed the 
closest relationship with sequence from China (Figure 2a), 
and L1 HPV-18 showed a closest relationship with sequence 
from Thailand (Figure 2b).  
1 kb           HPV-18        HPV16
2000 bp
1500 bp
Figure 1. Electrophoresis 
visualization of HPV-16 
and HPV-18 L1 genes.






































Figure 2. Phylogenetic tree of L1 genes. 
A: HPV-16 L1 gene; B: HPV-18 L1 gene.
Discussion
HPVs are characterized by a very slow mutation rate 
because they are DNA viruses that use the excellent DNA 
polymerase proofreading ability of their host to replicate 
their own genome. However, nucleotide polymorphisms can 
occur through random mutation and can become established 
in a population, therefore, HPVs have different distribution 
worldwide. This genetic change has been observed among 
HPV-16 and HPV-18 variants, suggesting their co-evolution 
with humankind over millions of years. (12,13) For example, 
the genomic diversity of alpha-7 HPV types ranged from 
1.1% to 6.7% nucleotide sequence differences. (14) Based 
on common phylogenetic patterns of single-nucleotide 
polymorphisms (SNPs) in the L1 viral genomic region, 
variation of HPV-16 can be classified phylogenetically into 
several variants, they are European (E), Asian (As), Asian-
American (AA) and African (Af), while, HPV18 variants 
originally were classified into African (Af), European (E) 
and Asian American (AA).(15,16) The phylogenetic analysis 
result for L1 gene of HPV-16 showed that the original isolate 
Bandung has the closest relationship with China, which 
includes subliniage Asia (bootstrap score = 60), in contrast 
to the Netherlands, Japan and the United States which are at 
separate positions on the phylogenetic tree. Bootstrap score 
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is a method to evaluate the feasibility of phylogenetic trees. 
Bootstrap above 50% indicates acceptable phylogenetic 
tree. This result suggests that the HPV-16 isolate Bandung 
has the same characteristic with HPV-16 originating from 
China, as confirmed in our previous study showing that 
the isolate from a patient with cervical cancer was in one 
subgroup with HPV from Asia and East Asia.(17) 
 Here we further explore the origin of the other HPV-
18 that infect in the same cervical cancer tissue as multiple 
infection. The phylogenetic analysis of HPV-18 L1 gene 
showed that HPV-18 isolates Bandung has the closest 
relationship with Thailand which is also a sublineage 
from Asia (boostrap score = 66), in contrast to Korea, the 
Netherlands, the United States and China that are at separate 
positions on the phylogenetic tree. This suggests that the 
HPV-18 isolate infecting this woman from Bandung has a 
characteristic equation with HPV-18 coming from Thailand. 
The distribution of HPV-18 sub-lineages varied according 
to geographical location. In the study, HPV-18 variants 
have been  grouped into three main groups, i.e., A, B and 
C. Groups A and B were divided into 4 sublineages. B and 
C lineages have been found in Africa. In the A lineage, the 
A1 sublineage predominated in eastern Asia and the Pacific, 
this includes HPV variant from China, Fiji, Indonesia, 
Thailand, Vietnam, Vanuatu, South Korea, the Philipines 
and Mongolia.(18) 
 The geographic distribution of HPV types and variants 
may be influenced by several factors, including coevolution 
of HPVs together with human races, human migration 
patterns, and viral transmissibility through sexual behaviour.
(19,20) The differences of host genetic factor, such as HLA 
haplotypes or TP53 polymorphisms, could have a role 
in the association between a particular HPV variant and 
cervical cancer development. In addition, the differences in 
HPVs variants can also be seen from the residual genetic 
heterogeneity within the HPV genomes. Thailand and 
China are located quite close to Indonesia geographically, 
therefore it may presumably cause dissemination and 
distribution of HPV lineage to Indonesia. In consequences, 
HPV from China and Thailand has L1 gene’s characteristics 
that tend to be the same with Indonesia as seen from the 
phylogenetic position of China and Thailand proved to be 
in a cluster with Indonesia in this research. This shows that 
both HPV isolates from cervical cancer patient in Bandung 
in our study are originated from Asia, as confirmed by our 
previous study.(17) Interestingly, our previous study has 
also showed that one of the HPV-16 genotypes variants was 
from African origin (Sahiratmadja, unpublished data). This 
results provided the valuable information about genetic 
diversity  of  L1  gene  of  HPV,  hence,  there  is  an  urgent 
need to  generate  full  genome  sequence  information, 
including L2 and  E  genes,  which  will  provide  a  clearer 
picture  of  the genetic diversity and evolution of HPVs 
Bandung.  
 The number of samples limits our study. Even though 
HPV-16 and HPV-18 are the most predominant HPV 
infecting the cervical cancer tissue in our samples, the 
multiple infection of both HPV-16 and HPV-18 genotypes 
is only found in a few samples. This may due to different 
HPV genotyping test used in this study, as our previous 
study shows more multiple infection compared to our recent 
study.(3) The HPV genotyping test result may vary and have 
different sensitivity/specificity in one to other test, thus, 
implicating the HPV genotype distribution and molecular 
epidemiology in a particular region.(21) Therefore, more 
multiple infection samples are needed. Analysis in many 
more HPV-16 samples in single infection or especially 
multiple infection may of great interest, as each HPV 
genotype has different oncogenic potentials encoded by E 
genes, and this limits our study that only exploring L1 gene. 
Further studies in E genes, especially E6 and E7 gene may 
add valuable information.
Conclusion
Phylogenetic analysis of both L1 gene in multiple infection 
of HPV-16 and HPV-18 that infect cervical cancer patient 
in our study shows a close relationship with sequence from 
Asia i.e., China and Thailand, respectively. 
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